Abbott Healthcare Products Limited

Solvay Healthcare, Mansbridge Road, West End, Southampton, SO18 3JD
Telephone: +44 (0)2380 467 000
Fax: +44 (0)2380 465 350
Medical Information e-mail: medinfo.shl@abbott.com
Customer Care direct line: +44 (0)1753 650 099
Medical Information Fax: +44 (0)2380 465 350

Patient Information Leaflet last updated on the eMC: 16/01/2012
PIL Arythmol 150mg and 300mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
Updated on 08/07/2010 and displayed until 16/01/2012
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 26/03/2009 and displayed until 08/07/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/12/2008 and displayed until 26/03/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
Updated on 26/09/2008 and displayed until 05/12/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 29/11/2007 and displayed until 26/09/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 22/11/2007 and displayed until 29/11/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 28/09/2006 and displayed until 22/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 11/12/2002 and displayed until 28/09/2006
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
   propafenone hydrochloride